针对严重急性支气管炎的儿科重症监护住院治疗的nirsevimab预防:临床和经济分析
Sarah Touati1, Alexandre Debs1, Luc Morin1,2
1IHU-PROMETHEUS Comprehensive Sepsis Center and Pediatric Intensive Care, Neonatal Medicine, and Pediatric Emergency Department, AP-HP Paris Saclay University, Bicêtre Hospital, 78 Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France.
Annals of intensive care
|April 25, 2025
概括
尼尔西维玛的预防措施显著减少了患有严重急性病毒性支气管炎的儿科重症监护室 (PICU) 住院人数. 这种针对呼吸道同胞性病毒 (RSV) 的单克隆抗体减少了 PICU 的停留时间和相关成本,减轻了 PICU 的冬季负担.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 严重的急性病毒性支气管炎是冬季儿科重症监护室 (PICU) 入院的主要原因.
- 用Nirsevimab进行的全方位新生儿预防,Nirsevimab是一种针对呼吸道同胞病毒 (RSV) 的单克隆抗体,在减少住院治疗方面表现有前途.
- 尼尔西维马布对支气管炎PICU入院的医疗经济影响需要进一步定义.
研究的目的:
- 评估Nirsevimab通用预防对严重急性病毒性支气管炎的PICU入院的影响.
- 评估在PICU中实施Nirsevimab的医疗经济后果.
主要方法:
- 在六个流行病时期 (2018-2024) 接受PICU重症急性支气管炎的婴儿的回顾性分析.
- 比较PICU入院率,患者特征,辅助疗法和Nirsevimab引入前后入院时间.
- 评估医疗经济影响,包括降低成本和投资回报.
主要成果:
- 在2023-2024年期间,与2022-2023年期间 (17.6%) 相比,PICU支气管炎入院的显著减少 (8.5%).
- 住院时间从4.4天减少到3.3天.
- 支气管炎入院的PICU总费用从每次流行病期间的210,105欧元降至121,044欧元.
结论:
- 使用Nirsevimab的全方位新生儿预防大大降低了PICU中严重急性病毒性支气管炎的负担.
- 尼尔西维玛布的实施导致了支气管炎的PICU管理中的显著成本节约.
- 该研究强调了Nirsevimab在减轻RSV诱导支气管炎对儿科重症监护资源的影响方面的有效性.
相关概念视频
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pneumonia IV: Management
264
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
264
Pneumonia I: Introduction
184
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
184
Acute Respiratory Failure-V
107
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
107


